Search

Author/Creator Klausen, Uffe

1. An immunogenic first-in-human immune modulatory vaccine with PD-L1 and PD-L2 peptides is feasible and shows early signs of efficacy in follicular lymphoma. (1st January 2021)

Authors:
Klausen, Uffe; Grønne Dahlager Jørgensen, Nicolai; Grauslund, Jacob Handlos; Munir Ahmad, Shamaila; Gang, Anne Ortved; Martinenaite, Evelina; Weis-Banke, Stine Emilie; Breinholt, Marie Fredslund; Novotny, Guy Wayne; Kjeldsen, Julie Westerlin; Orebo Holmström, Morten; Pedersen, Lone Bredo; Poulsen...
Journal:
Oncoimmunology
Issue:
Volume 10:Number 1(2021)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. The inhibitory checkpoint, PD-L2, is a target for effector T cells: Novel possibilities for immune therapy. (1st February 2018)

Authors:
Ahmad, Shamaila Munir; Martinenaite, Evelina; Holmström, Morten; Jørgensen, Mia Aaboe; Met, Özcan; Nastasi, Claudia; Klausen, Uffe; Donia, Marco; Pedersen, Lars Møller; Munksgaard, Lars; Ødum, Niels; Woetmann, Anders; Svane, Inge Marie; Andersen, Mads Hald
Journal:
Oncoimmunology
Issue:
Volume 7:Number 2(2018)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search